daunorubicin has been researched along with Carcinoma, Transitional Cell in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aass, N; Fosså, SD; Parö, G | 1 |
| Biondo, F; Caramia, G; Gebbia, N; Pavone-Macaluso, M; Rausa, L; Rizzo, FP | 1 |
1 trial(s) available for daunorubicin and Carcinoma, Transitional Cell
| Article | Year |
|---|---|
A phase II study of DaunoXome in advanced urothelial transitional cell carcinoma.
Topics: Aged; Antibiotics, Antineoplastic; Carcinoma, Transitional Cell; Chest Pain; Daunorubicin; Female; Hematologic Diseases; Humans; Liposomes; Male; Treatment Failure; Urologic Neoplasms | 1998 |
1 other study(ies) available for daunorubicin and Carcinoma, Transitional Cell
| Article | Year |
|---|---|
Experimental techniques for testing the sensitivity of bladder tumours to antineoplastic drugs.
Topics: Administration, Topical; Animals; Antineoplastic Agents; Carcinoma, Transitional Cell; Cell Nucleus; Cricetinae; Cytotoxicity Tests, Immunologic; Daunorubicin; Demecolcine; DNA, Neoplasm; Doxorubicin; Drug Resistance; Fluorescence; Glycosides; Humans; Melphalan; Microscopy, Fluorescence; Neoplasm Transplantation; Oxidoreductases; Podophyllotoxin; Protein Biosynthesis; Thiophenes; Thiotepa; Transplantation, Heterologous; Urinary Bladder Neoplasms | 1973 |